China
· Delayed Price · Currency is CNY Shanghai Pharmaceuticals Holding Statistics
Total Valuation
Shanghai Pharmaceuticals Holding has a market cap or net worth of CNY 68.44 billion. The enterprise value is 92.74 billion.
| Market Cap | 68.44B |
| Enterprise Value | 92.74B |
Important Dates
The next estimated earnings date is Monday, October 28, 2024.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | Sep 24, 2024 |
Share Statistics
Shanghai Pharmaceuticals Holding has 3.70 billion shares outstanding. The number of shares has increased by 0.15% in one year.
| Shares Outstanding | 3.70B |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | +1.70% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 14.25% |
| Float | 1.83B |
Valuation Ratios
The trailing PE ratio is 18.83 and the forward PE ratio is 16.41. Shanghai Pharmaceuticals Holding's PEG ratio is 1.77.
| PE Ratio | 18.83 |
| Forward PE | 16.41 |
| PS Ratio | 0.29 |
| PB Ratio | 1.10 |
| P/FCF Ratio | 61.49 |
| PEG Ratio | 1.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.09, with an EV/FCF ratio of 74.30.
| EV / Earnings | 22.62 |
| EV / Sales | 0.35 |
| EV / EBITDA | 9.09 |
| EV / EBIT | 11.34 |
| EV / FCF | 74.30 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.33 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 5.57 |
| Debt / FCF | 45.57 |
| Interest Coverage | 4.44 |
Financial Efficiency
Return on equity (ROE) is 6.64% and return on invested capital (ROIC) is 3.78%.
| Return on Equity (ROE) | 6.64% |
| Return on Assets (ROA) | 2.35% |
| Return on Capital (ROIC) | 3.78% |
| Revenue Per Employee | 5.43M |
| Profits Per Employee | 83,278 |
| Employee Count | 48,164 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 6.94 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.17% in the last 52 weeks. The beta is 0.30, so Shanghai Pharmaceuticals Holding's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +23.17% |
| 50-Day Moving Average | 19.36 |
| 200-Day Moving Average | 18.19 |
| Relative Strength Index (RSI) | 54.75 |
| Average Volume (20 Days) | 16,684,495 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shanghai Pharmaceuticals Holding had revenue of CNY 267.12 billion and earned 4.10 billion in profits. Earnings per share was 1.10.
| Revenue | 267.12B |
| Gross Profit | 29.92B |
| Operating Income | 8.18B |
| Pretax Income | 7.34B |
| Net Income | 4.10B |
| EBITDA | 9.50B |
| EBIT | 8.18B |
| Earnings Per Share (EPS) | 1.10 |
Balance Sheet
The company has 44.82 billion in cash and 56.89 billion in debt, giving a net cash position of -12.07 billion or -3.26 per share.
| Cash & Cash Equivalents | 44.82B |
| Total Debt | 56.89B |
| Net Cash | -12.07B |
| Net Cash Per Share | -3.26 |
| Equity (Book Value) | 82.23B |
| Book Value Per Share | 18.90 |
| Working Capital | 42.50B |
Cash Flow
In the last 12 months, operating cash flow was 4.11 billion and capital expenditures -2.86 billion, giving a free cash flow of 1.25 billion.
| Operating Cash Flow | 4.11B |
| Capital Expenditures | -2.86B |
| Free Cash Flow | 1.25B |
| FCF Per Share | 0.34 |
Margins
Gross margin is 11.20%, with operating and profit margins of 3.06% and 1.53%.
| Gross Margin | 11.20% |
| Operating Margin | 3.06% |
| Pretax Margin | 2.75% |
| Profit Margin | 1.53% |
| EBITDA Margin | 3.56% |
| EBIT Margin | 3.06% |
| FCF Margin | 0.47% |
Dividends & Yields
This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 2.00%.
| Dividend Per Share | 0.41 |
| Dividend Yield | 2.00% |
| Dividend Growth (YoY) | -19.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 98.08% |
| Buyback Yield | -0.15% |
| Shareholder Yield | 1.85% |
| Earnings Yield | 5.31% |
| FCF Yield | 1.63% |
Stock Splits
The last stock split was on August 16, 2007. It was a forward split with a ratio of 1.2.
| Last Split Date | Aug 16, 2007 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Shanghai Pharmaceuticals Holding has an Altman Z-Score of 2.06. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.06 |
| Piotroski F-Score | n/a |